Home > Quotes > DSCI > Press Releases

Derma Sciences, Inc. Press Releases

DSCI 
$14.29
*  
0.06
  negative  
0.42%
Get DSCI Alerts
*Delayed - data as of May 17, 2013 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.


Don't know the stock symbol? Use the symbol lookup tool.

Alphabetize the sort order of my symbols 
Symbol Lookup
Log in or Register
 Save stocks for next time
 | Sponsored
Viewing
Filtered By
Ordered By

Derma Sciences Reports First Quarter 2013 Financial Results
05/16/2013 7:30AM - Business Wire

Derma Sciences Engages Plexus Ventures to Explore Strategic Options for DSC127 Outside the U.S.
05/14/2013 7:30AM - Business Wire

Derma Sciences to Hold First Quarter Financial Results Conference Call on May 16th
05/07/2013 7:30AM - Business Wire

Derma Sciences Begins Screening Patients in Second Phase 3 Trial with DSC127 for Healing Diabetic Foot Ulcers
04/25/2013 4:01PM - Business Wire

Derma Sciences to Present at the 12th Annual Needham Healthcare Conference
04/22/2013 3:13PM - Business Wire

Faruqi & Faruqi, LLP Launches an Investigation against Derma Sciences, Inc. (DSCI) for Potential Breaches of Fiduciary Duties by Its Board of Directors
04/19/2013 8:30PM - Business Wire

Derma Sciences Expands TCC-EZ® Market Reach with Long-Term Exclusive Global Rights Agreement
04/01/2013 7:10AM - Business Wire

Derma Sciences Reports 2012 Fourth Quarter and Full Year Financial Results
04/01/2013 7:00AM - Business Wire

Derma Sciences Announces Timing for Fourth Quarter Conference Call and 2012 Form 10-K Filing
03/15/2013 4:44PM - Business Wire

Derma Sciences to Present at the 25th Annual ROTH Conference
03/14/2013 12:17PM - Business Wire